Tag archive

Francisco Duque III

Ban on use of Dengvaxia stays—DOH’s Duque

in News/Tabloid PH News
Ban on use of Dengvaxia stays—DOH’s Duque
image credit: twitter / @secduque

Despite calls from several groups to allow the limited use of Dengvaxia amid the dengue epidemic, the Department of Health (DOH) announced on Thursday (August 22) that the appeal of Sanofi Pasteur seeking to reverse the revocation of its certificate of product registration (CPR) for the dengue vaccine has been thumbed down.

Health Secretary Francisco Duque III said the denial of Sanofi’s appeal dated August 19 was due to the French manufacturer’s “continued failure to submit post-approval requirements.”

Dengvaxia’s CPR was canceled by the Food and Drug Administration (FDA) last February, effectively banning the use of the vaccine in the country.

“The decision concerns Sanofi’s complete disregard of FDA regulations, which were precisely put in place by law to ensure safety,” Duque said.

He added: “The DOH is committed to strong and strict implementation of our health laws and regulations. We know how critical this is to our efforts to rebuild public trust and confidence in our public health programs and in vaccines that have long been proven effective.” 

He, however, clarified that Sanofi can still apply for a new CPR for Dengvaxia, especially at this time when the country is in a state of national dengue epidemic, with the number of dengue cases about to breach 200,000 already this year.

Even President Duterte had said he is open to the use of Dengvaxia again. ”Now, compare it vis-à-vis to those who died, I want to hear the words of the experts, doctors, and we have enough bright people to tell us. I don’t need foreigners to tell me, my own Filipino scientists and doctors would tell me what to do. I will be guided by their announcements,” he said.

Sanofi failed to submit its third risk management plan (RMP), a post-marketing requirement meant to ensure public safety.

It also failed to submit fresh data on its “pharmacovigilance and post-marketing surveillance” programs. 

These reports should detail the monitoring of Dengvaxia’s effects on some 830,000 students vaccinated through the Dengue Immunization Program at the tail end of the Aquino administration in 2016.

Senators to start Philhealth probe even sans Duque

in News/Tabloid PH News
Senators to start Philhealth probe even sans Duque

Senators are bent on starting its probe on the reported multibillion-peso scam at the state-run Philippine Health Insurance Corp. (PhilHealth) even if Health Secretary Francisco Duque III would not be able to attend the first hearing as he supervises efforts to address the dengue outbreak in the country.

Duque will be quizzed by members of the Senate Blue Ribbon Committee for his alleged involvement in the overpayment of Philhealth benefits to hospitals and the reported dealings of his family-owned companies with Philhealth and the Department of Health (DOH)

Senator Richard Gordon, chairman of the committee, said he wants hearings to start by Friday, with former officials of Philhealth and DOH already summoned to answer queries from the senators.

Gordon said they want to establish immediately how Philhealth funds are being managed and what led to the overpayment of benefits to hospitals that caused the state corporation to lose P154 billion.

In his State of the Nation Address last Monday, President Duterte said he already ordered the National Bureau of Investigation (NBI) to identify all the officials of public and private institutions involved in the hospital bogus claims. 

Senator Panfilo Lacson, on the other hand, wants Duque to explain to the committee why the DOH and Philhealth had contracts with corporations owned by the Health secretary’s family.

Lacson, according to a report of the Philippine Daily Inquirer,  criticized Duque for allowing Philhealth to lease a space in a family-owned building in Dagupan City, Pangasinan. The Duque-owned Doctors’ Pharmaceuticals Inc. (DPI), meanwhile, supplied medicines to DOH. Lacson, the report added, also linked Duque to the reported overpayments of PhilHealth to private hospitals, including one supposedly owned by a godson of the health chief. 

These, Lacson said, constitute a conflict of interest. 

It was Lacson who exposed the bogus claims scam involving Philhealth and certain hospitals and clinics.

Duque has already informed the Blue Ribbon Committee that he is currently too preoccupied with the dengue outbreak and will not be able to attend the Senate probe.

Go to Top